Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome

Description

Chronic pain is a major complaint among many individuals living with hypermobile Ehlers Danlos Syndrome (hEDS) and may have a severe impact on quality of life and activities of daily living. Given the complexity of the disease's pathophysiology, effective treatments are limited. This investigation will examine the impacts of green light exposure on subject-reported pain severity and symptoms. Knowing whether this intervention can improve pain and quality of life in this population may offer valuable guidance to clinicians who treat hEDS patients and to hEDS patients themselves.

Conditions

Ehlers-Danlos Syndrome, Pain, Chronic

Talk to us

Study Overview

On this page

Study Details

Study overview

Chronic pain is a major complaint among many individuals living with hypermobile Ehlers Danlos Syndrome (hEDS) and may have a severe impact on quality of life and activities of daily living. Given the complexity of the disease's pathophysiology, effective treatments are limited. This investigation will examine the impacts of green light exposure on subject-reported pain severity and symptoms. Knowing whether this intervention can improve pain and quality of life in this population may offer valuable guidance to clinicians who treat hEDS patients and to hEDS patients themselves.

Investigation of Light Exposure on Pain Severity and Quality of Life in Individuals With Hypermobile Ehlers-Danlos Syndrome: A Pilot Study

Light Exposure on Pain in Hypermobile Ehlers-Danlos Syndrome

Condition
Ehlers-Danlos Syndrome
Intervention / Treatment

-

Contacts and Locations

Old Westbury

New York Institute of Technology College of Osteopathic Medicine, Old Westbury, New York, United States, 11568

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. 18 years of age or older and able to speak, read, and understand English
  • 2. Diagnosed with hEDS
  • 3. Average numeric pain score of 5 out of 10 or greater over the 10 weeks prior to enrolling in the study and failure of medical therapy to control the pain
  • 1. Initiation of any new analgesic therapy within 30 days of enrollment (note: chronic therapy with a stable regimen maintained for at least 30 days prior to enrollment is permitted)
  • 2. Serious mental illness, defined as distortions of perception, delusions, hallucinations, and unusual behaviors resulting in loss of contact with reality or Major Depression Disorder
  • 3. History of color blindness or uncorrected cataracts
  • 4. Receiving remuneration, or litigation pending, for their medical conditions

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

New York Institute of Technology,

Philip Noto, DO, PRINCIPAL_INVESTIGATOR, NYITCOM

Study Record Dates

2025-11